Abstract
PurposeThe guideline physical activity levels are prescribed in terms of time, frequency, and intensity (e.g., 30 minutes brisk walking, five days a week or its energy equivalence) and assume that different activities may be combined to meet targeted goals (exchangeability premise). Habitual runners and walkers may quantify exercise in terms of distance (km/day), and for them, the relationship between activity dose and health benefits may be better assessed in terms of distance rather than time. Analyses were therefore performed to test: 1) whether time-based or distance-based estimates of energy expenditure provide the best metric for relating running and walking to hypertensive, high cholesterol, and diabetes medication use (conditions known to be diminished by exercise), and 2) the exchangeability premise.MethodsLogistic regression analyses of medication use (dependent variable) vs. metabolic equivalent hours per day (METhr/d) of running, walking and other exercise (independent variables) using cross-sectional data from the National Runners' (17,201 male, 16,173 female) and Walkers' Health Studies (3,434 male, 12,384 female).ResultsEstimated METhr/d of running and walking activity were 38% and 31% greater, respectively, when calculated from self-reported time than distance in men, and 43% and 37% greater in women, respectively. Percent reductions in the odds for hypertension and high cholesterol medication use per METhr/d run or per METhr/d walked were ≥2-fold greater when estimated from reported distance (km/wk) than from time (hr/wk). The per METhr/d odds reduction was significantly greater for the distance- than the time-based estimate for hypertension (runners: P<10−5 for males and P = 0.003 for females; walkers: P = 0.03 for males and P<10−4 for females), high cholesterol medication use in runners (P<10−4 for males and P = 0.02 for females) and male walkers (P = 0.01 for males and P = 0.08 for females) and for diabetes medication use in male runners (P<10−3).ConclusionsAlthough causality between greater exercise and lower prevalence of hypertension, high cholesterol and diabetes cannot be inferred from these cross-sectional data, the results do suggest that distance-based estimates of METhr/d run or walked provide superior metrics for epidemiological analyses to their traditional time-based estimates.
Highlights
Physical activity recommendations are defined in terms of duration, frequency, and intensity (e.g., i.e., 150 minutes per week of moderate aerobic physical activity or 75 minutes of vigorous aerobic physical activity per week), and they assume that different activities can be combined to meet targeted goals [1,2,3,4,5,6]
Estimated metabolic equivalent hours per day (METhr/d) of running activity was 38% greater when calculated from self-reported time and intensity than from self-reported weekly distance in men, and 43% greater in women
Estimated METhr/d of walking activity was 31% greater when calculated from time and intensity vis-a-vis from distance in men, and 37% greater in women
Summary
Physical activity recommendations are defined in terms of duration (time), frequency, and intensity (e.g., i.e., 150 minutes per week of moderate aerobic physical activity or 75 minutes of vigorous aerobic physical activity per week), and they assume that different activities can be combined to meet targeted goals (exchangeability premise) [1,2,3,4,5,6]. A number of health benefits have been ascribed to longer weekly distances run (equivalent to running energy expenditure [24]) or walked, benefits that continue to accrue at higher activity levels and for additional disease endpoints than reported for time-based estimates of exercise energy expenditure [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23] In part, this might be due to self-reported distance in habitual runners and walkers being more reliably reported than self-reported intensity and duration in other populations. A direct comparison of a time-based and distancebased estimation of energy expenditure in their relationship to hypertension, high-cholesterol and diabetes in runners and walkers has not been previously reported
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have